Variant report
Variant | esv3330444 |
---|---|
Chromosome Location | chr2:50583350-50599057 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543784886 | chr2:50583367-50583368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144260735 | chr2:50583423-50583424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569825165 | chr2:50583430-50583431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565174087 | chr2:50583452-50583453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150162265 | chr2:50583468-50583469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4638832 | chr2:50583489-50583490 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs370377074 | chr2:50583573-50583574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544016731 | chr2:50583578-50583579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111310187 | chr2:50583581-50583582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373840519 | chr2:50583606-50583607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs368585733 | chr2:50583607-50583608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557063490 | chr2:50583641-50583642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181104528 | chr2:50583672-50583673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577214634 | chr2:50583698-50583699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577492543 | chr2:50583807-50583808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545880443 | chr2:50583819-50583820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375678508 | chr2:50583909-50583910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138734831 | chr2:50583931-50583932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369864837 | chr2:50583956-50583957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs61481177 | chr2:50583975-50583976 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs536778027 | chr2:50583980-50583981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552149737 | chr2:50583983-50583984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148922514 | chr2:50583991-50583992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184615799 | chr2:50584007-50584008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534624383 | chr2:50584078-50584079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74822848 | chr2:50584114-50584115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575122133 | chr2:50584119-50584120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574414584 | chr2:50584124-50584125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs76306924 | chr2:50584130-50584131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556774118 | chr2:50584180-50584181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77168138 | chr2:50584203-50584204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374248615 | chr2:50584213-50584214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559843774 | chr2:50584214-50584215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543598703 | chr2:50584235-50584236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535545923 | chr2:50584261-50584262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577122045 | chr2:50584297-50584298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541452778 | chr2:50584323-50584324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368767800 | chr2:50584330-50584331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138278876 | chr2:50584398-50584399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185913493 | chr2:50585046-50585047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546402070 | chr2:50585068-50585069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191282196 | chr2:50585080-50585081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528207216 | chr2:50585082-50585083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565405452 | chr2:50585094-50585095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567764910 | chr2:50585116-50585117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139471045 | chr2:50585171-50585172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs6727675 | chr2:50585175-50585176 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs569148320 | chr2:50585177-50585178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182422748 | chr2:50585189-50585190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557958634 | chr2:50585203-50585204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Autism | 20531469 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50581400-50583400 | Weak transcription | Fetal Brain Female | brain |
2 | chr2:50582800-50584000 | Enhancers | Fetal Brain Male | brain |
3 | chr2:50583400-50584400 | Enhancers | Fetal Brain Female | brain |
4 | chr2:50585000-50585600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr2:50597400-50598600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr2:50598200-50598600 | Enhancers | HUES64 Cell Line | embryonic stem cell |